Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential intrathecal hyperbaric versus hyperbaric + isobaric bupivacaine in orthogeriatric lower limb surgery
PACTR202002695592368Completed
- Sponsor
- Mansoura University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bupivacaine (2 arms), sponsored by Mansoura University. Primary endpoint: Incidence of arterial hypotension. Started Feb 2020; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on PACTR202002695592368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202002695592368.